Susceptibility to cytomegalovirus, parvovirus B19 and age‐dependent differences in levels of rubella antibodies among pregnant women
Identifieur interne : 001733 ( Istex/Curation ); précédent : 001732; suivant : 001734Susceptibility to cytomegalovirus, parvovirus B19 and age‐dependent differences in levels of rubella antibodies among pregnant women
Auteurs : Regine Barlinn [Norvège] ; Kirsti Vainio [Norvège] ; Helvi Holm Samdal [Norvège] ; Svein Arne Nordb [Norvège] ; Hanne N Kleby [Norvège] ; Susanne G. Dudman [Norvège]Source :
- Journal of Medical Virology [ 0146-6615 ] ; 2014-05.
Abstract
Infections caused by cytomegalovirus (CMV), parvovirus B19 (B19), and rubella can lead to serious complications in pregnant women. The aim of this study was to determine the susceptibility to CMV, B19, and rubella antibodies in pregnant women in Norway. Consecutive sera samples were collected from pregnant women in two different regions in Norway. Sera were collected from age groups; ≤19, 20–24, 25–29, 30–34, 35–39, and ≥40 years old. Of the 2,000 pregnant women tested, anti‐CMV IgG was positive in 62.8% anti‐parvovirus B19 IgG in 59.7% and anti‐rubella IgG in 94.4%. CMV IgG susceptibility has decreased in pregnant women less than 30 years of age, from 60% in a study conducted in 1973–1974 to 37.2% in present study. There was a significant difference in CMV IgG seropositivity rate between the two regions (58.6% and 67.1%). Serum levels of rubella IgG was lowest in age group 25–29 years with a positivity rate of 91.0%. Women born before vaccination with two doses of MMR started, had both a higher positivity rate and significantly higher levels of rubella antibody titre, 96.1% and 82.2 IU/ml compared to those born after 92.9% and 41.7 IU/ml. Significantly lower anti‐rubella IgG titre found in the youngest age groups highlights the need for continued antenatal screening. A considerable increase in anti‐CMV‐IgG seropositivity rate was observed and might be associated with higher rate of breastfeeding and a higher percentage attending day‐care centres. J. Med. Virol. 86:820–826, 2014. © 2013 Wiley Periodicals, Inc.
Url:
DOI: 10.1002/jmv.23757
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001733
Links to Exploration step
ISTEX:9C31DB4359124C9600FA240EE47A0B1C84671950Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Susceptibility to cytomegalovirus, parvovirus B19 and age‐dependent differences in levels of rubella antibodies among pregnant women</title><author><name sortKey="Barlinn, Regine" sort="Barlinn, Regine" uniqKey="Barlinn R" first="Regine" last="Barlinn">Regine Barlinn</name><affiliation wicri:level="1"><mods:affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Virology, Norwegian Institute of Public Health, Oslo</wicri:regionArea></affiliation><affiliation><mods:affiliation>Correspondence to: Regine Barlinn, Department of Virology, Norwegian Institute of Public Health, PO Box 4404 Nydalen, 0403 Oslo, Norway.E‐mail:</mods:affiliation><wicri:noCountry code="subField">Norway.E‐mail:</wicri:noCountry></affiliation><affiliation wicri:level="1"><mods:affiliation>E-mail: regine.barlinn@fhi.no</mods:affiliation><country wicri:rule="url">Norvège</country></affiliation></author><author><name sortKey="Vainio, Kirsti" sort="Vainio, Kirsti" uniqKey="Vainio K" first="Kirsti" last="Vainio">Kirsti Vainio</name><affiliation wicri:level="1"><mods:affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Virology, Norwegian Institute of Public Health, Oslo</wicri:regionArea></affiliation></author><author><name sortKey="Samdal, Helvi Holm" sort="Samdal, Helvi Holm" uniqKey="Samdal H" first="Helvi Holm" last="Samdal">Helvi Holm Samdal</name><affiliation wicri:level="1"><mods:affiliation>Department of Medical Microbiology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Medical Microbiology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Current Address: Department of Microbiology, Oslo University Hospital, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Current Address: Department of Microbiology, Oslo University Hospital, Oslo</wicri:regionArea></affiliation></author><author><name sortKey="Nordb, Svein Arne" sort="Nordb, Svein Arne" uniqKey="Nordb S" first="Svein Arne" last="Nordb">Svein Arne Nordb</name><affiliation wicri:level="1"><mods:affiliation>Department of Medical Microbiology St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Medical Microbiology St. Olavs Hospital, Trondheim University Hospital, Trondheim</wicri:regionArea></affiliation></author><author><name sortKey="N Kleby, Hanne" sort="N Kleby, Hanne" uniqKey="N Kleby H" first="Hanne" last="N Kleby">Hanne N Kleby</name><affiliation wicri:level="1"><mods:affiliation>Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo</wicri:regionArea></affiliation></author><author><name sortKey="Dudman, Susanne G" sort="Dudman, Susanne G" uniqKey="Dudman S" first="Susanne G." last="Dudman">Susanne G. Dudman</name><affiliation wicri:level="1"><mods:affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Virology, Norwegian Institute of Public Health, Oslo</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9C31DB4359124C9600FA240EE47A0B1C84671950</idno><date when="2014" year="2014">2014</date><idno type="doi">10.1002/jmv.23757</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-SZV2H8JK-1/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001733</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001733</idno><idno type="wicri:Area/Istex/Curation">001733</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Susceptibility to cytomegalovirus, parvovirus B19 and age‐dependent differences in levels of rubella antibodies among pregnant women</title><author><name sortKey="Barlinn, Regine" sort="Barlinn, Regine" uniqKey="Barlinn R" first="Regine" last="Barlinn">Regine Barlinn</name><affiliation wicri:level="1"><mods:affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Virology, Norwegian Institute of Public Health, Oslo</wicri:regionArea></affiliation><affiliation><mods:affiliation>Correspondence to: Regine Barlinn, Department of Virology, Norwegian Institute of Public Health, PO Box 4404 Nydalen, 0403 Oslo, Norway.E‐mail:</mods:affiliation></affiliation><affiliation wicri:level="1"><mods:affiliation>E-mail: regine.barlinn@fhi.no</mods:affiliation><country wicri:rule="url">Norvège</country></affiliation></author><author><name sortKey="Vainio, Kirsti" sort="Vainio, Kirsti" uniqKey="Vainio K" first="Kirsti" last="Vainio">Kirsti Vainio</name><affiliation wicri:level="1"><mods:affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Virology, Norwegian Institute of Public Health, Oslo</wicri:regionArea></affiliation></author><author><name sortKey="Samdal, Helvi Holm" sort="Samdal, Helvi Holm" uniqKey="Samdal H" first="Helvi Holm" last="Samdal">Helvi Holm Samdal</name><affiliation wicri:level="1"><mods:affiliation>Department of Medical Microbiology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Medical Microbiology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Current Address: Department of Microbiology, Oslo University Hospital, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Current Address: Department of Microbiology, Oslo University Hospital, Oslo</wicri:regionArea></affiliation></author><author><name sortKey="Nordb, Svein Arne" sort="Nordb, Svein Arne" uniqKey="Nordb S" first="Svein Arne" last="Nordb">Svein Arne Nordb</name><affiliation wicri:level="1"><mods:affiliation>Department of Medical Microbiology St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Medical Microbiology St. Olavs Hospital, Trondheim University Hospital, Trondheim</wicri:regionArea></affiliation></author><author><name sortKey="N Kleby, Hanne" sort="N Kleby, Hanne" uniqKey="N Kleby H" first="Hanne" last="N Kleby">Hanne N Kleby</name><affiliation wicri:level="1"><mods:affiliation>Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo</wicri:regionArea></affiliation></author><author><name sortKey="Dudman, Susanne G" sort="Dudman, Susanne G" uniqKey="Dudman S" first="Susanne G." last="Dudman">Susanne G. Dudman</name><affiliation wicri:level="1"><mods:affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway</mods:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Virology, Norwegian Institute of Public Health, Oslo</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of Medical Virology</title><title level="j" type="alt">JOURNAL OF MEDICAL VIROLOGY</title><idno type="ISSN">0146-6615</idno><idno type="eISSN">1096-9071</idno><imprint><biblScope unit="vol">86</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="820">820</biblScope><biblScope unit="page" to="826">826</biblScope><biblScope unit="page-count">7</biblScope><date type="published" when="2014-05">2014-05</date></imprint><idno type="ISSN">0146-6615</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0146-6615</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Infections caused by cytomegalovirus (CMV), parvovirus B19 (B19), and rubella can lead to serious complications in pregnant women. The aim of this study was to determine the susceptibility to CMV, B19, and rubella antibodies in pregnant women in Norway. Consecutive sera samples were collected from pregnant women in two different regions in Norway. Sera were collected from age groups; ≤19, 20–24, 25–29, 30–34, 35–39, and ≥40 years old. Of the 2,000 pregnant women tested, anti‐CMV IgG was positive in 62.8% anti‐parvovirus B19 IgG in 59.7% and anti‐rubella IgG in 94.4%. CMV IgG susceptibility has decreased in pregnant women less than 30 years of age, from 60% in a study conducted in 1973–1974 to 37.2% in present study. There was a significant difference in CMV IgG seropositivity rate between the two regions (58.6% and 67.1%). Serum levels of rubella IgG was lowest in age group 25–29 years with a positivity rate of 91.0%. Women born before vaccination with two doses of MMR started, had both a higher positivity rate and significantly higher levels of rubella antibody titre, 96.1% and 82.2 IU/ml compared to those born after 92.9% and 41.7 IU/ml. Significantly lower anti‐rubella IgG titre found in the youngest age groups highlights the need for continued antenatal screening. A considerable increase in anti‐CMV‐IgG seropositivity rate was observed and might be associated with higher rate of breastfeeding and a higher percentage attending day‐care centres. J. Med. Virol. 86:820–826, 2014. © 2013 Wiley Periodicals, Inc.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001733 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001733 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:9C31DB4359124C9600FA240EE47A0B1C84671950
|texte= Susceptibility to cytomegalovirus, parvovirus B19 and age‐dependent differences in levels of rubella antibodies among pregnant women
}}
| This area was generated with Dilib version V0.6.33. |  |